OptiFer Alpha

Heme iron oral supplement.
For the prevention of iron deficiency and iron deficiency anemia. OptiFer is designed for individuals who require effective iron replenishment — particularly women of reproductive age, pregnant women, and patients who have not tolerated conventional non-heme iron supplementation. The product addresses a high-prevalence clinical gap in Women’s Health and Hematology, where adherence to iron therapy is frequently compromised by gastrointestinal tolerability.

Mechanism of Action Heme iron polypeptide is absorbed via a receptor-mediated pathway that is distinct from the non-heme iron transporter (DMT-1), rendering absorption significantly less susceptible to dietary inhibitors such as phytates, calcium, and polyphenols. This specialized transport mechanism enables higher bioavailability at a lower elemental iron dose compared to conventional iron salts (e.g., ferrous sulfate, fumarate, gluconate). Because heme iron bypasses many of the rate-limiting steps that generate free iron in the gastrointestinal lumen, it produces markedly fewer oxidative insults to the gut mucosa, resulting in reduced rates of constipation, nausea, and abdominal discomfort. The net clinical effect is effective replenishment of hematological parameters — including hemoglobin, ferritin, MCV, and MCH — with a tolerability profile that supports sustained patient adherence.

Key Differentiators

• Only heme iron recognized by the SOGC: OptiFer Alpha is the first and only heme iron supplement recognized by the Society of Obstetricians and Gynaecologists of Canada, conferring a unique clinical endorsement that no competing product holds in the Canadian market.
• Superior absorption with reduced GI burden: Heme iron’s specialized absorption pathway delivers higher bioavailability than non-heme iron salts at a lower elemental iron dose (11 mg/tablet), directly addressing the compliance crisis caused by GI side effects that plague conventional iron therapy.
• Pregnancy-safe with Health Canada backing: Explicitly indicated for use in pregnancy and safe during breastfeeding, with dosing aligned to Health Canada’s recommended intake for pregnant women — a critical differentiator in the maternal health segment.
• Broadest retail footprint in category: Available nationally at Costco, Shoppers Drug Mart, and major Canadian pharmacy chains, providing market access scale that supports both patient pull-through and HCP confidence.
• Fastest-growing product in its category: OptiFer Alpha’s trajectory reflects growing HCP adoption and consumer demand for a clinically credible, tolerable alternative to legacy iron supplements — signalling strong commercial momentum for a licensing partner.
• Premium quality certifications: Gluten-free, Halal certified, GMO-free, manufactured to European standards — attributes that broaden the addressable patient population and support premium positioning.

Target Prescribers

• Obstetricians & Gynecologists
• Family Physicians & General Practitioners
• Midwives & Nurse Practitioners
• Hematologists
• Dietitians & Registered Nutritionists
• Pharmacists (as primary recommendation point of care)

Patient Profile